New Zealand markets open in 6 hours 35 minutes

Immunovant, Inc. (IMVT)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
28.73+0.21 (+0.74%)
As of 11:25AM EDT. Market open.
Full screen
Loading interactive chart…
  • Insider Monkey

    Should You Hold Immunovant (IMVT)?

    Baron Funds, an investment management company, released its “Baron Health Care Fund” first quarter 2024 investor letter. A copy of the same can be downloaded here. The fund advanced 8.92% (Institutional Shares) in the quarter compared to an 8.52% gain for the Russell 3000 Health Care Index (benchmark) and a 10.56% increase for the S&P […]

  • Zacks

    Here's Why You Should Add Immunovant (IMVT) to Your Portfolio

    Immunovant's (IMVT) late-stage studies evaluating its lead candidate, batoclimab, for various autoimmune indications are progressing well. Several data readouts are expected in 2024 and 2025.

  • Zacks

    What Makes Immunovant (IMVT) a New Buy Stock

    Immunovant (IMVT) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).